Table 1.
Proliferation and apoptosis with cotreatment in vitro
| DMSO | BICA | RK33 | BICA+RK33 | ||
| Ki67 | Cell Line | ||||
| Percent | BCaPMT10 | 51.4 (43.2–59.5) | 53.2 (48.3–58.2) | 43.4 (40.4–46.5) | 26.9 (22.4–31.5) |
| Positivity | C42 | 85.7 (79–92.5) | 75.5 (72.2–78.8) | 73.4 (71.2–75.5) | 54.1 (48.6–59.6) |
| cCASP3 | |||||
| Percent | BCaPMT10 | 4.76 (4.29–5.24) | 5.26 (4.13–6.37) | 6.76 (6.6–6.92) | 9.45 (7.84–11.1) |
| Positivity | C42 | 1.09 (0.91–1.28) | 1.73 (0.85–2.61) | 1.96 (1.69–2.21) | 4.3 (2.92–5.68) |
*Values show mean percent positivity for n = 3 with the 95% confidence intervals in parentheses. Bolded text indicates significance compared to DMSO (P < 0.05), and italicized text indicates significance compared to BICA alone (P < 0.05).